skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: A few years ago my former broker recommended stochta.com which shows free technical charts and more. For charts of Canadian companies add .c to the symbol. I hope this is useful to some members. Thanks for the great service, Frank
Read Answer Asked by Frank on July 09, 2018
Q: What are your BEST 5 ideas for a TSFA account. Thanks Valter.
Read Answer Asked by Valter on July 09, 2018
Q: I wish to add more fixed income to both my Can $ and US$ portfolios. Reviewing recent Q & A has given me information for Canadian options. Can you suggest US$ Etf's for US and/or international exposure. Thanks for your help and continuing good advice. Doug
Read Answer Asked by Doug on July 06, 2018
Q: With reference to Sheldon's question on Recognia and MACD crossovers, a free resource for positive and negative crossovers can be found here:
http://stockcharts.com/def/servlet/SC.scan
Read Answer Asked by Randy on July 06, 2018
Q: On June 27, in response to Kolbi's question on the marijuana industry, 5i said, "If you are not smoking now you are not likely to become a pothead in October."

Respectfully, I wish to offer an alternative view. I'm 69, and haven't smoked pot since the 70s as I don't want to deal with people in drug culture. However I'm looking forward to buying some pot among the scores of varieties that will be available. I think it will enhance other enjoyments. I was talking to my girlfriend about smoking dope and I felt like I was 20 again. If this is how I'm thinking, I'm willing to bet that many of my generation, as well as those younger and older, will also take advantage of a marijuana industry that is legal, open, and staffed by knowledgeable people.

So yeah, I'm totally looking forward to becoming a pothead in October.
Read Answer Asked by Jerry on July 06, 2018
Q: I'm thinking the sell off of these two stocks is overdone due primarily to all the uncertainty around trade and tariffs.
For a longer term hold (3-5 years) would consider this to be a good time to step in (perhaps a half position) or should I wait for these matters to be clarified/resolved?
Thanks, Rick
Read Answer Asked by Richard on July 06, 2018
Q: I notice that DBX is declining today while most tech companies are doing well. I’m wondering what the reason is for the relative weakness and if that’s a bad sign. What’s the valuation like after the drop?

Also, in a recent answer you referred to BOX and DBX as the two best in their sector. Did you mean “cloud computing” as a sector? Perhaps you could name a few of their rivals to give me a better idea of what you meant. Thanks.
Read Answer Asked by Brian on July 06, 2018
Q: Healthcare is approximately 10% of our portfolio. Medical Facilities is the largest investment which we have held for a long time. JNJ and HCP we have added more recently. NVS and AZN we inherited. We want to simplify our portfolio and plan to sell NVS and AZN and add to JNJ. Wonder what your opinion is of DR and HCP specifically and also AZN which I didn't see mentioned in your question section.
Thank you, Marie
Read Answer Asked by J on July 06, 2018
Q: I am currently light in Healthcare & Materials. Companies that I currently hold are COV, CSH.UN, GUD, CCL.B, MX & WEF. Can you suggest three stocks in each sector that I could add?

Thanks, Dave
Read Answer Asked by Dave on July 06, 2018
Q: I realize you have better prospects than these but I am wondering if you can make a buy case for longer term holds. Could you also provide some of your current small cap favorites . Thanx Robbie
Read Answer Asked by Robert on July 06, 2018
Q: The GUD investing thesis is largely based on management including past success with Paladin. Paladin was certainly a well run company and created lots of value for shareholders so credit to management is not misplaced. But, do you think that the ultimate success with Paladin was more a function of incredibly lucky timing to have been taken out during a really crazy pharma cycle? In other words, how much credit goes to management and how much goes to a once in a generation crazy pharma cycle?
Read Answer Asked by Joel on July 06, 2018
Q: Morning,
I need some help to understand an "outperform" rating recently issued by RBC on CAR,un.
When the report was issued a day or two ago CAR was trading at $42.63 and only had a yield of 3.1%. RBC has given a $40 price target in 12 months.
Why would there be an outperform rating on a stock that may have a negative return in the next year?
I feel CAR is extremely overvalued at this time and have reduced my holdings by 25%. What is your opinion?
Thanks for the help.
John
Read Answer Asked by John on July 06, 2018
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!